Medication - Medika Life

CATEGORIES

Medication

Beyond Stereotypes: The Exceptional Abilities That Make Autistic Minds Invaluable

Pat Farrell PhD - June 1, 2025

2024 Health Trends: Progress, Challenges, and Opportunities

Gil Bashe, Medika Life Editor - December 27, 2024

The New Covid Vaccine Is Out. Why You Might Not Want To Rush To Get It

Medika Life - September 22, 2024

10-Year-Old Killers Are Responsible for Their Actions?

Pat Farrell PhD - September 5, 2024

LATEST

Editors Choice

The Power of Lifestyle Choices – The Dose of Truth in “Heal Thyself”

John Whyte MD - April 24, 2022

General Health

Chiropractic Care May Led to Reduced Opioid Use

Dr Erik Reich - February 18, 2022

Press Release

New National Survey of People Living with Bipolar I Disorder Provides Insights Into Disease-Related Challenges and the Treatment Journey

Medika Life - January 12, 2022

Digital Innovation

Exponential Innovation: Disrupting The Disruptor

John Nosta - January 5, 2022

Anxiety and Depression

Does Botox Drop Anxiety?

Michael Hunter, MD - December 23, 2021

Neurological

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston - June 8, 2021

Addiction

How Suboxone Set Me Free From Opiate Addiction

Macarthur Medical Center - June 2, 2021

Research Critique

The MDMA-Assisted Therapy for PTSD Study. What You’ll Get Wrong

James Coyne - May 25, 2021

News and Views

Is the New York Times a Shill for Promoters of Psychedelics?

James Coyne - May 18, 2021

Mental Health

Blaming the Psychiatric Patient When It’s a Drug-Genetic Interaction

Medika Life - February 26, 2021

1 234 Page 3 of 4

TRENDING

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life - January 9, 2023

SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults Approved

Medika Life - August 12, 2020

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston - June 8, 2021

The Power of Lifestyle Choices – The Dose of Truth in “Heal Thyself”

John Whyte MD - April 24, 2022

Exponential Innovation: Disrupting The Disruptor

John Nosta - January 5, 2022

Psilocybin as an Antidepressant for Cancer Patients Who Are Not Depressed

James Coyne - December 14, 2020

Do Medications Have Psychiatric Side Effects?

Pat Farrell PhD - October 6, 2020

Does Botox Drop Anxiety?

Michael Hunter, MD - December 23, 2021

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

James Coyne - December 14, 2020

Depression isn’t Caused by Low Serotonin Level, Are SSRIs still Effective?

Isabella Soerjanto MD - August 2, 2022

EDITORS CHOICE

10-Year-Old Killers Are Responsible for Their Actions?

Pat Farrell PhD - September 5, 2024

Should society hold children who murder accountable for such acts?

The 50 Most Influential Leaders in Pharmacy 2022 Awards

Medika Life - January 9, 2023

Today the Pharmacy Podcast Network announces the winners of the 50 Most Influential Leaders in Pharmacy 2023 Awards.

Psychedelics and Mental Health

Michael Hunter, MD - May 4, 2023

THERE IS A GROWING INTEREST IN HALLUCINOGENS, especially regarding their application for psychiatric disorders.

FDA Approval of New Drug for Alzheimer’s Offers Hope

Dr Jeff Livingston - June 8, 2021

The FDA approves Aduhelm for the treatment of early Alzheimer's disease. Aduhelm targets brain plaque formation to slow the rate of cognitive decline.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories